Miguel Tovarflipped into Pharma readings Novartis' migraine drug gets EMA approval pharmatimes.com Aimovig becomes Europe’s first treatment specifically designed to prevent migraine
Miguel Tovarflipped into Pharma readings Pfizer CEO on what happened after Trump tweeted verified_publisherCNBC - Meg Tirrell Before he even spoke to the president, Pfizer CEO Ian Read said he knew the best move was to defer the drug giant's early July price increases; a …
Miguel Tovarflipped into Pharma readings Kyoto team pits iPS cells against Parkinson's disease japantimes.co.jp - No Author A Kyoto University research team said Monday it will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson’s …
Miguel Tovarflipped into Pharma readings Highly Anticipated Data On Would-Be Alzheimer's Drug Raises Hope And Questions Forbes - Ellie KincaidHow does Biogen Chief Medical Officer Al Sandrock feel after the curtain was lifted on clinical trial data of the experimental Alzheimer’s drug his company is developing with Japanese drugmaker Eisai?...
Miguel Tovarflipped into Pharma readings GSK bets $300 million on genetics as CEO plays down break-up talk verified_publisherReuters - Ben HirschlerLONDON (Reuters) - GlaxoSmithKline aims to turbo-charge its drug discovery engine with a big bet on genetics as its CEO on Wednesday played down the idea of hiving off consumer healthcare, which is a of...
Miguel Tovarflipped into Pharma readings Eisai, Biogen battered by controversy over PhII Alzheimer's study after posting positive results endpts.com - John Carroll At first blush, Eisai and Biogen posted the kind of promising data for BAN2401 that might have overcome some doubts about its potential as a …
Miguel Tovarflipped into Pharma readings 23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs Forbes - Matthew HerperGlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will a...
Miguel Tovarflipped into Pharma readingsNovartis Novartis's Cultural Revolution Will Be AI-Enabled, Desk-Free verified_publisherBloomberg - James Paton When sales staff at drugmaker Novartis AG wake up each morning, an artificial-intelligence program will soon tell them how best to organize their …
Miguel Tovarflipped into Pharma readings Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It Forbes - Matthew Herperhat, exactly, is this meeting for?” It might seem an odd, even brusque question, especially when asked to the CEO of a major pharmaceutical company by a recently hired employee. But it’s how Hal Barron,...
Miguel Tovarflipped into Pharma readingsQuote Symbol https://www.nytimes.com/2018/07/23/us/politics/trump-drug-prices.html Miguel Tovar
Miguel Tovarflipped into Pharma readingsClinical Trials Top Alzheimer’s researchers hope that near-100 dementia drugs in trials are moving closer to a breakthrough verified_publisherCNBC - Kelly Song The search for an Alzheimer’s disease cure has been dogged by pharmaceutical failures, but a network of the world’s top dementia scientists released …
Miguel Tovarflipped into Pharma readingsNovartis Novartis to Pay as Much as $1 Billion for Skin Drug Rights verified_publisherBloomberg - Thomas Mulier Novartis AG agreed to buy the rights to a skin-disease drug from developers Galapagos NV and MorphoSys AG in a deal that could reach $1 billion as …
